Abstract This American Head and Neck Society (AHNS) consensus statement focuses on
the detection and management of recurrent thyroid cancer. This document describes the …

Background Invasive differentiated thyroid cancer (DTC) is relatively frequent, yet there is a
paucity of specific guidelines devoted to its management. The Endocrine Committee of the …

Objective To discuss the risk of recurrence in patients with differentiated thyroid cancer and
emphasize the importance of risk-group stratification. Methods Common risk factors …

Simple Summary Surgery is generally the treatment of choice for locoregional recurrences of
well-differentiated thyroid carcinomas, but other therapies can be considered on an …

Introduction: Management of recurrent differentiated thyroid cancer (DTC) may include
surgery, radioactive iodine (RAI), and external beam radiotherapy (EBRT). Systemic therapy …

The lack of prospective randomized clinical trials for most management topics in
differentiated thyroid cancer forces us to make management recommendations based on …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …

Historically, thyroid cancers have received relatively little attention from the medical
oncology community. As recently as the 2005 Annual Meeting of the American Society of …

Recurrent thyroid cancer: a molecular-based therapeutic brea... : Current Opinion in
Oncology Recurrent thyroid cancer: a molecular-based therapeutic breakthrough : Current …

Background Well‐differentiated thyroid cancer (WDTC) recurs in up to 30% of patients.
Guidelines from the American Thyroid Association (ATA) and the National Comprehensive …